Quantbot Technologies LP purchased a new stake in Humana Inc. (NYSE:HUM) during the third quarter, according to the company in its most recent filing with the SEC. The firm purchased 27,801 shares of the insurance provider’s stock, valued at approximately $6,773,000. Humana comprises 0.6% of Quantbot Technologies LP’s investment portfolio, making the stock its 18th biggest position.
Several other institutional investors and hedge funds also recently made changes to their positions in the business. Cambridge Investment Research Advisors Inc. lifted its holdings in shares of Humana by 35.5% during the 3rd quarter. Cambridge Investment Research Advisors Inc. now owns 2,838 shares of the insurance provider’s stock valued at $691,000 after acquiring an additional 743 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. lifted its holdings in shares of Humana by 1.4% during the 3rd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 438,594 shares of the insurance provider’s stock valued at $106,855,000 after acquiring an additional 6,250 shares in the last quarter. DekaBank Deutsche Girozentrale lifted its holdings in shares of Humana by 1.9% during the 3rd quarter. DekaBank Deutsche Girozentrale now owns 54,192 shares of the insurance provider’s stock valued at $13,560,000 after acquiring an additional 1,023 shares in the last quarter. Rhumbline Advisers lifted its holdings in shares of Humana by 3.5% during the 3rd quarter. Rhumbline Advisers now owns 259,908 shares of the insurance provider’s stock valued at $63,321,000 after acquiring an additional 8,827 shares in the last quarter. Finally, Todd Asset Management LLC acquired a new position in shares of Humana during the 3rd quarter valued at $501,000. Institutional investors own 96.15% of the company’s stock.
In other Humana news, insider Elizabeth D. Bierbower sold 9,786 shares of the business’s stock in a transaction dated Friday, September 1st. The shares were sold at an average price of $259.00, for a total transaction of $2,534,574.00. Following the completion of the transaction, the insider now directly owns 18,042 shares of the company’s stock, valued at approximately $4,672,878. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Timothy S. Huval sold 7,803 shares of the business’s stock in a transaction dated Friday, September 1st. The shares were sold at an average price of $258.14, for a total transaction of $2,014,266.42. Following the transaction, the vice president now directly owns 8,831 shares of the company’s stock, valued at $2,279,634.34. The disclosure for this sale can be found here. Insiders have sold a total of 20,660 shares of company stock valued at $5,319,600 over the last three months. 0.80% of the stock is currently owned by company insiders.
Shares of Humana Inc. (NYSE:HUM) traded down $6.28 during trading hours on Thursday, hitting $233.28. 1,618,700 shares of the company were exchanged, compared to its average volume of 1,380,572. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 0.35. Humana Inc. has a twelve month low of $186.25 and a twelve month high of $264.56. The company has a market cap of $34,223.56, a P/E ratio of 20.44, a PEG ratio of 1.65 and a beta of 0.91.
Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, November 8th. The insurance provider reported $3.39 earnings per share for the quarter, beating analysts’ consensus estimates of $3.27 by $0.12. Humana had a net margin of 3.49% and a return on equity of 15.99%. The business had revenue of $13.28 billion during the quarter, compared to the consensus estimate of $13.41 billion. During the same quarter in the prior year, the firm earned $3.18 EPS. The company’s revenue for the quarter was down 3.0% compared to the same quarter last year. analysts expect that Humana Inc. will post 11.63 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, December 29th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.69%. The ex-dividend date of this dividend is Thursday, December 28th. Humana’s dividend payout ratio is presently 12.59%.
COPYRIGHT VIOLATION WARNING: This news story was posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this news story on another publication, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The legal version of this news story can be accessed at https://ledgergazette.com/2017/11/16/quantbot-technologies-lp-purchases-shares-of-27801-humana-inc-hum.html.
HUM has been the topic of several recent research reports. UBS AG restated a “neutral” rating and set a $250.00 target price (up previously from $237.00) on shares of Humana in a report on Wednesday, August 9th. Zacks Investment Research lowered shares of Humana from a “hold” rating to a “sell” rating in a report on Thursday, July 27th. BidaskClub upgraded shares of Humana from a “sell” rating to a “hold” rating in a report on Thursday, August 10th. Cantor Fitzgerald reiterated a “neutral” rating and issued a $223.00 price objective (up previously from $200.00) on shares of Humana in a report on Thursday, August 3rd. Finally, Jefferies Group LLC reiterated a “hold” rating and issued a $257.00 price objective on shares of Humana in a report on Friday, August 4th. Thirteen analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. Humana presently has a consensus rating of “Hold” and an average target price of $252.81.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.